Neurocrine Biosciences (NBIX) stock is in focus after the company reported second quarter 2026 revenue of US$959 million and ...
The cool news is that the latest data from the Federal Reserve’s preferred inflation indicator came in lower than consensus in June, primarily due to a drop in energy prices. The not-so-cool news?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results